Evidence map›Paper›PMID 33173156›Full record

ArticleScientific reports2020

Integrating single-cell RNA-seq and imaging with SCOPE-seq2.

Zhouzerui Liu, Jinzhou Yuan, Anna Lasorella, Antonio Iavarone, Jeffrey N Bruce, Peter Canoll, Peter A Sims

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Robotic data acquisition with deep learning enables cell image-based prediction of transcriptomic phenotypes.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Dynamics ofProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhouzerui LiuDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Jinzhou YuanDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Anna LasorellaInstitute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Antonio IavaroneInstitute for Cancer Genetics, Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Jeffrey N BruceDepartment of Neurological Surgery, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Peter CanollDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA.
Peter A SimsDepartment of Systems Biology, Columbia University Irving Medical Center, New York, NY, 10032, USA. pas2182@cumc.columbia.edu.

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
Topology of Cancer Evolution and HeterogeneityU54CA193313 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI IAVARONE, ANTONIO, RABADAN, RAUL · 2015 to 2020
$10.4M
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment RecurrenceR01NS103473 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JEFFREY N BRUCE, Peter Canoll · 2017 to 2026
$4.3M
Fully integrated single cell imaging and RNA-Seq library preparationR44HG010003 · NHGRI · CELL MICROSYSTEMS, INC. · PI GEBHART, STEVEN CHARLES · 2018 to 2019
$1.5M
Large-Scale Integration of Single Cell RNA-Seq and High-Content Imaging for Analyzing Drug Response in CancerR33CA202827 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SIMS, PETER ALAN · 2016 to 2018
$948k
NCI NIH HHS P30 CA013696NCI NIH HHS R33CA202827NCI NIH HHS U54CA193313NHGRI NIH HHS R44HG010003NINDS NIH HHS R01NS103473
6 · The paper itself

Abstract

Live cell imaging allows direct observation and monitoring of phenotypes that are difficult to infer from transcriptomics. However, existing methods for linking microscopy and single-cell RNA-seq (scRNA-seq) have limited scalability. Here, we describe an upgraded version of Single Cell Optical Phenotyping and Expression (SCOPE-seq2) for combining single-cell imaging and expression profiling, with substantial improvements in throughput, molecular capture efficiency, linking accuracy, and compatibility with standard microscopy instrumentation. We introduce improved optically decodable mRNA capture beads and implement a more scalable and simplified optical decoding process. We demonstrate the utility of SCOPE-seq2 for fluorescence, morphological, and expression profiling of individual primary cells from a human glioblastoma (GBM) surgical sample, revealing relationships between simple imaging features and cellular identity, particularly among malignantly transformed tumor cells.

Indexed as

3T3 CellsAnimalsCell Line, TumorGene Expression ProfilingGlioblastomaHigh-Throughput Nucleotide SequencingHumansMiceMicroscopy, FluorescenceOptical ImagingSequence Analysis, RNASingle-Cell AnalysisTumor Cells, Cultured

Identifiers

PMID33173156
PMCPMC7655825

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.